Blue Faery

2024 Annual Report

2024: Year of Growing Pains

With growth comes growing pains. In 2024, we experienced some growing pains. Small but mighty, we expanded our team to five full-time employees when we hired Susan Hall as our development manager in September. We gained a new board director, Jen Peters, and several new volunteers. We parted ways with a vendor but found a new one. We’ve developed systems to ensure consistency with our vision, mission, values, strategic objective, and general operating principles.

Our programs have grown, too! Our Liver Cancer Community continues to thrive with Sharon Dixon as our Community Ambassador. We continued The Truth About Liver Cancer program and launched You and Liver Cancer. Our Love Your Liver program maintained its focus on different minority populations. Our Blue Faery Award increased by 65% and Dr. Peter Galle, a renowned HCC expert, won the 2024 BFA award. He is our third international recipient.

We are deeply grateful to AstraZeneca, Bayer, Eisai, Elevar Therapeutics, Eureka Therapeutics, Exelixis, Genentech, and Merck for their support.

Thank you for believing in our mission.

Fighting Liver Cancer Together
Andrea Wilson Woods
President and Founder

Blue Faery’s US Team at The Liver Meeting in November 2024 in San Diego, California

Our Mission has never wavered …

To prevent, treat, and cure primary liver cancer, specifically Hepatocellular Carcinoma (HCC), through research, education, and advocacy. Our work will improve the quality of life for HCC patients, support their caregivers, and give them hope, information, and a voice.

About Liver Cancer

Hepatocellular carcinoma (HCC) is the fourth most common cancer in the world and the third most common cause of cancer deaths worldwide. HCC accounts for more than 90% of primary liver cancers worldwide.

HCC is also known as hepatoma, primary liver cell carcinoma, or primary liver cancer. The number of incident cases increased by 75% between 1990 and 2015, mostly because of changes in population age structures and population growth.

Approximately, 90% of HCC cases are associated with a known underlying cause, most commonly chronic viral hepatitis, heavy alcohol use, and non-alcoholic fatty liver disease.*

*https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121295/

Liver Cancer Statistics

Over 905,000 new cases each year

Over 830,000 deaths each year

3rd leading cause of cancer deaths

55% increase in liver cancer cases
by 2040

Our Programs

Liver Cancer Community

for HCC patients and families

As of December 2024,

688 all-time members
72 daily active members

Hosted on HealthUnlocked, Blue Faery’s Liver Cancer Community is a private, online, HIPAA-compliant forum composed of HCC patients and caregivers who support each other throughout their cancer journey.

Patient Resource Guides for Liver Cancer

We finished distributing the third edition in Q1 2025

32,000 English Copies

5,000 Spanish Copies

3,000 Chinese Copies

United States

Distribution of the 3rd edition from Winter 2023 to Spring 2025

Order Patient Resource Guides

The Truth About Liver Cancer

The Truth About Liver Cancer (TTALC) educates the public about HCC through a series of live, virtual, 90-minute workshops throughout the year held on Saturdays at 12 p.m. EST.

Watch The Truth About Liver Cancer Playlist on YouTube

TTALC 2024 Panelists

Melinda Bachini

Clinical Trials
Cholangiocarcinoma Survivor
Steve Baum

Liver and Kidney Transplant
Polycystic Kidney Disease Survivor
Karen Hoyt

Liver Transplant
HCC survivor
Tony Villiotti

Liver Transplant
HCC Survivor
Angela Davis

Caregivers Corner
Spouse of HCC patient
Elisa Herr

Caregivers Corner
Spouse of HCC patient
Betsy Villiotti

Caregivers Corner
Spouse of HCC patient
Jeff Cape

Unsung Heroes
Caregiver of HCC patient
Kara Klink

Unsung Heroes
Former oncology social worker and HCC patient
Jessica Kropack

Unsung Heroes
Liver tumor coordinator and nurse navigator
Dr. Bridget Bongaard

Rural Realities
Internal medicine physician in Maui
Lorrinda Gray-Davis

Rural Realities
Liver cancer survivor

Love Your Liver

The best way to stop liver cancer is to prevent it before it happens.

Blue Faery’s Love Your Liver program spreads awareness and educates high-risk, underserved populations to increase the prevention and early detection of liver disease and cancer. Given that minorities have higher rates of liver cancer, Love Your Liver seeks to improve health inequities and address social determinants of health. Asian Americans and Pacific Islanders have the highest rates of liver cancer, followed by Hispanics/Latinos, American Indians/Alaska Natives, African Americans, and whites.

All Love Your Liver programs are culturally inclusive, in their native language, and led by healthcare providers who reflect the community.

Love Your Liver for Asian Americans in May 2024

Asian Americans are 2x more likely than White Americans to get chronic hepatitis B, the leading cause of liver cancer in the Asian American community.

During Asian American and Pacific Islander Heritage Month, Blue Faery has free educational programs for Asian Americans.

Love Your Liver for Blacks/African Americans in February 2024

Blacks/African Americans are 1.5x more likely than White Americans to get liver cancer, and incidence rates are rising.

During Black History Month, Blue Faery has free educational programs for the Black community.

Love Your Liver for Hispanic Americans in Sept/Oct 2024

Hispanics are 2.5x more likely than White Americans to develop liver cancer.

During Hispanic Heritage Month (September 15 – October 15), Blue Faery has free educational programs for the Hispanic community.

You and Liver Cancer

In collaboration with Mechanisms in Medicine Inc., Blue Faery designed this program to meet the educational needs of patients and caregivers affected by liver cancer.

Watch You and Liver Cancer Playlist on YouTube